New Research Shows Self-Collected Tests Perform Similarly to Provider-Collected Tests for Detecting STIs
By LabMedica International staff writers Posted on 27 Jul 2023 |

New research presented at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo has shown that self-collected tests are as effective as provider-collected tests in detecting prevalent sexually transmitted infections (STIs). These findings could pave the way for new, discreet testing options that expand access to STI screening.
The human papillomavirus (HPV) is a primary cause of cervical cancer in the U.S., creating the need for regular testing as part of prevention and screening measures. Testing traditionally occurs in clinical environments, but there's increasing interest in using self-collected samples for HPV and other STIs. Such self-administered tests could potentially benefit those who find it difficult to access healthcare providers due to their location, profession, or fear of stigma or discrimination. Nevertheless, additional research is needed to confirm the reliability of these self-collected tests.
Researchers from LetsGetChecked Laboratories (New York, NY, USA) and the Permanente Medical Group (Oakland, CA, USA) performed a comparative study on HPV tests using 144 pairs of self-collected vaginal swabs and healthcare provider-collected swabs from the cervix lining. Additionally, they exposed a small selection of self-collected samples to temperatures that simulate extreme seasonal fluctuations. To assess the variability in swabs from a single individual, likely due to differing virus quantities in each swab, the researchers evaluated five self-collected swabs from 15 participants.
Lastly, the team explored methods to enhance the collection process, like modifying the duration samples were left to dry and providing participants with an instructional video. The majority of self-collected samples delivered results consistent with those from provider-collected ones. Differences were attributed to smaller amounts of detectable virus in self-collected samples. Those samples exposed to extreme temperatures had less detectable virus than those not subjected to such conditions. However, changes in the drying time of samples did not affect virus detection. Sample validity saw an improvement of 8.5% after participants viewed an instructional video.
“We performed a detailed analysis of the variables related to self-collected vaginal swabs to calculate analytical acceptability metrics, and to identify limitations in testing that can be improved to aid in modern cervical cancer screening,” said primary author Michelle Qi.
In another study, researchers from the Los Angeles County Department of Public Health (Baldwin Park, CA, USA) and LetsGetChecked analyzed the performance of self-collected tests versus provider-collected tests for two common sexually transmitted infections (STIs): Chlamydia trachomatis and Neisseria gonorrhea. These infections frequently present without symptoms, making them challenging to detect. The Centers for Disease Control and Prevention suggest that self-collected samples, obtained from urine or swabs of the vagina, rectum, or throat, could serve as practical alternatives to provider-collected samples. At present, only urine and vaginal swabs can be self-collected within clinics. This research was initiated with the aim of broadening the inclusivity and accessibility of STI testing by examining more options for self-collection and home testing.
The researchers evaluated results from 164 pairs of rectal swabs collected at home and by providers, and 159 pairs of throat swabs. They also conducted tests on urine and vaginal swabs to determine the effects of temperature fluctuations, contamination from hands, and inaccurate filling of self-collected urine samples. When compared to provider-collected samples, the self-collected rectal swabs showed 95.5% positive agreement for C. trachomatis and a perfect 100% for N. gonorrhea. Meanwhile, self-collected throat swabs were nearly 100% consistent with provider-collected swabs for both infections. Notably, there were several swabs that tested positive for both pathogens when self-collected but tested negative when collected by providers. The presence of hand contaminants had a negligible impact on test outcomes, and the results remained largely unaltered by temperature fluctuations and incorrect filling of urine samples.
“Self-collected rectal and throat swabs could offer better sensitivity than those collected by physicians for detecting C. trachomatis and N. gonorrhea—without compromising the test’s analytical performance,” said Breland Hockman, Ph.D., one of the study’s authors. “Therefore, specimens of STIs collected at home offer a viable option for improving access to STI screening and could offer a non-stigmatizing approach to sexual health.”
Related Links:
LetsGetChecked Laboratories
Permanente Medical Group
LA County Public Health
Latest AACC 2023 News
- First-of-Its-Kind Single-Cell Clinical Microbiology Platform Wins 2023 Disruptive Technology Award
- Ground-Breaking Phage-Based Diagnostic Kit for Laboratory Tuberculosis Testing Presented at AACC 2023
- Laboratory Experts Show How They Are Leading the Way on Global Trends
- Unique Competition Focuses on Using Data Science to Forecast Preanalytical Errors
- Best Approach to Infectious Disease Serology Testing for Laboratorians and Clinicians Discussed at AACC 2023
- Breaking Research Throws Light on COVID, Flu, and RSV Co-Infections
- AI Predicts Multiple Sclerosis Risk, Flags Potentially Contaminated Lab Results
- Scientific Session Explores Role of Technology in New Era of Specimen Transport
- Prevencio Presents AI-Driven Platform for Medical Diagnostic Test Development
- Scientific Session Explores Future Role of AI and ML in Clinical Laboratory
- SARSTEDT Demonstrates Pre-Analytic Innovations for Improving Specimen Quality, Reducing TAT and Automating Labs
- World's First Large Sample Volume, Open-Assay, Super-fast, Ultra-Sensitive, and Sample-To-Answer PCR Instrument
- Vital Biosciences Unveils Revolutionary POC Lab Testing Platform
- World's Smallest POC Device for Complete Blood Count in 30 Minutes Unveiled
- General Biologicals Unveils CTC Cancer Detection Products and Automated Molecular System
- Fapon Showcases Innovative Diagnostic and Biopharma Solutions
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreMolecular Diagnostics
view channel
Rapid Diagnostic Test to Halt Mother-To-Child Hepatitis B Transmission
Hepatitis B, an inflammation of the liver caused by the hepatitis B virus (HBV), is the second-leading infectious cause of death globally, following tuberculosis. This viral infection can result in serious... Read more
Simple Urine Test Could Help Patients Avoid Invasive Scans for Kidney Cancer
Clear cell renal cell carcinoma (ccRCC) is the most prevalent type of kidney cancer, making up approximately 90% of cases. Each year, around 400,000 individuals are diagnosed with ccRCC globally.... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions
In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read moreCerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
In recent years, cancer immunotherapy has emerged as a promising approach where the patient's immune system is harnessed to fight cancer. One form of immunotherapy, called CAR-T-cell therapy, involves... Read more
New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more
Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read moreMicrobiology
view channelInnovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
Each year, 11 million people across the world die of sepsis out of which 1.3 million deaths are due to antibiotic-resistant bacteria. The burden of antimicrobial resistance (AMR) continues to weigh heavily,... Read more
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read morePathology
view channel
Powerful AI Tool Diagnoses Coeliac Disease from Biopsy Images with Over 97% Accuracy
Coeliac disease is an autoimmune disorder triggered by the consumption of gluten, causing symptoms such as stomach cramps, diarrhea, skin rashes, weight loss, fatigue, and anemia. Due to the wide variation... Read more
Pre-Analytical Conditions Influence Cell-Free MicroRNA Stability in Blood Plasma Samples
Scientists worldwide are working to enhance the quality of diagnostics and prognosis for various diseases, including cancer, by analyzing different body fluids such as blood, urine, and saliva.... Read more
3D Cell Culture System Could Revolutionize Cancer Diagnostics
New drugs and diagnostic methods should ideally be both safe and quickly accessible, but the preclinical testing phase often hinders rapid progress due to the high level of resources it requires.... Read more
Painless Technique Measures Glucose Concentrations in Solution and Tissue Via Sound Waves
Blood glucose levels are traditionally measured using invasive methods that require pricking the skin with small needles. However, for individuals with diabetes, frequent testing throughout the day becomes... Read moreTechnology
view channel
Smartphones Could Diagnose Diseases Using Infrared Scans
Rapid advancements in technology may soon make it possible for individuals to bypass invasive medical procedures by simply uploading a screenshot of their lab results from their phone directly to their doctor.... Read more
Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
Metabolites are critical compounds that fuel life's essential functions, playing a key role in producing energy, regulating cellular activities, and maintaining the balance of bodily systems.... Read more
3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
Microfluidic devices are diagnostic systems capable of analyzing small volumes of materials with precision and speed. These devices are used in a variety of applications, including cancer cell analysis,... Read moreIndustry
view channel
Philips and Ibex Expand Partnership to Enhance AI-Enabled Pathology Workflows
Royal Philips (Amsterdam, The Netherlands) has expanded its partnership with Ibex Medical Analytics (Tel Aviv, Israel) and released the new Philips IntelliSite Pathology Solution (PIPS) to further accelerate... Read more
Grifols and Inpeco Partner to Deliver Transfusion Medicine ‘Lab of The Future’
Grifols (Barcelona, Spain), a manufacturer of plasma-derived medicines and innovative diagnostic solutions, has entered into a strategic agreement with Inpeco (Novazzano, Switzerland), a global leader... Read more